期刊文献+

血清N末端脑钠肽前体早期诊断蒽环类药物心脏毒性的实验研究 被引量:1

Serum NT-proBNP as a Marker for Early Detection for Anthracycline-induced Cardiotoxicity in Rabbits
下载PDF
导出
摘要 目的:探讨血清N末端脑钠肽前体(NT-proBNP)浓度是否可成为蒽环类药物心脏毒性的早期诊断指标。方法:新西兰雄性兔44只随机分为对照组和实验组,对照组新西兰兔静脉注射等体积的生理盐水,实验组分为4组,每次给予阿霉素2 mg/kg,每周1次,根据给药周数不同,分为1周组、2周组、4周组和8周组。经胸超声心动图测量左室射血分数(LVEF)和左室短轴缩短分数(FS)以及E峰和A峰比率,血清NT-proBNP浓度测量采用酶联免疫吸附测定法(ELISA),心肌光镜Billingham评分和电镜检查评价蒽环类药物心脏毒性。结果:8周组新西兰兔LVEF、FS以及E/A比率均下降(P<0.05),4周组新西兰兔心肌病评分高于对照组、1周组和2周组(P<0.05)。八周组新西兰兔心肌病评分高于其余各组新西兰兔(P<0.05)。心肌电镜检查结果证实二周组、四周组和八周组新西兰兔心肌损伤。与对照组血清NT-proBNP浓度相比,二周组、四周组和八周组新西兰兔血清NT-proBNP浓度均明显上升(P<0.05)。通过相关分析提示血清NT-proBNP浓度与阿霉素累积剂量及心肌损害的程度呈正相关。结论:血清NT-proBNP浓度可能是蒽环类药物心脏毒性较早期诊断指标。 Objective:To investigate serum NT-proBNP concentrations as an early biomarker for anthracycline-induced myocardial damage in rabbits. Methods: 44 male rabbits were randomly divided into control group or one of four doxorubicin groups. Rabbits in control group received saline, while rabbits in doxorubicin group received 2 mg/kg doxorubicin weekly for one (Group 1), two (Group 2), four (Group 3) and eight(Group 4)weeks. Echocardiography was performed to measure left ventricular ejection fraction (LVEF), fractional shortening (FS), and E/A ratio. Serum NT-proBNP concentrations were quantified by a rabbit-specific enzyme-linked immunosorbent assay (ELISA). Cardiotoxicity scores were determined by light microscopy using Billingham's method and by electron microscopy. Results: Decreased LVEF, FS, and E/A ratio were detected in Group 4 (P 〈 0.05). The Billingham cardiomyopathy scores of the rabbits in Group 3 were significantly higher (P 〈 0.05) than those of rabbits in control group or Groups 1 or 2. The Billingham cardiomyopathy scores in Group 4 were the highest of all five groups (P 〈 0.05). Myocardial injury was verified by electron microscopy in rabbits from Groups 2, 3, and 4. Compared with control group, serum NT-proBNP concentrations increased in Groups 2, 3, and 4 (P 〈 0.05). A positive correlation between the serum NT- proBNP concentrations and both the dose of doxorubicin and the cardiomyopathy score was found. Conclusion: Serum NT-proBNP concentrations may be a sensitive method for assessing early cardiotoxicity induced by anthracycline.
出处 《岭南急诊医学杂志》 2012年第4期243-245,248,共4页 Lingnan Journal of Emergency Medicine
基金 广东省卫生厅医学科学基(B2009088)
关键词 N末端脑钠肽前体 心脏毒性 阿霉素 蒽环类药物 NT-proBNP cardiotoxicity Doxorubicin Anthracycline
  • 相关文献

参考文献7

  • 1Di lauro L, Giacinti L, Arena MG,et al. Phase study ofepirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma [J]. J Exp Clin Cancer Res,2009,28 (1):28.
  • 2Pai VB,Nahata MC.Cardiotoxicity of chemotherapeutic agents: incidence,treatment and prevention [J].Drug Saf, 2000,22 (4): 263.
  • 3Dodos F,Halbsguth T,Erdmann E,et al.Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline -induced cardiotoxicity in adults [J]. Clin Res Cardiol,2008,97 (5) : 318.
  • 4Erkus B,Demirtas S,Yarpuzlu AA,et al. Early prediction of anthracycline induced cardiotoxicity [J]. Acta Paediatr, 2007,96 (4) : 506.
  • 5Kilickap S,Barista I,Akgul E,et al. cTnT can be a useful marker for early detection of anthracycline cardiotoxicity [J]. Ann oncol, 2005,16 (5): 798.
  • 6Galvani M, Ottani F, Oltrona L,et al. N-terminal pro- brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes [J]. Circulation, 2004,110 (2): 128.
  • 7苗海卫,罗心平,黄成磊,王逸平,孙伟康.阿霉素心肌病兔模型心肌损害变化的研究[J].实验动物与比较医学,2009,29(1):1-5. 被引量:4

二级参考文献6

  • 1李文强,李艳,魏捷,李国草,李庚山.扩张型心肌病家兔血浆脑钠肽水平的改变及其意义[J].中国危重病急救医学,2005,17(3):161-164. 被引量:16
  • 2Singal PK, Iliskovic N. Doxorubicin2induced cardiomyopathy [J]. N Engl J Med, 1998, 339: 900-905.
  • 3Hrdina R, Gerel V, Klimtova I, et al. Anthracycline-induced Cardiotoxicity [J]. Actamedica(Hradec Kralove), 2000, 43:75-82.
  • 4Schwarz ER, Pollick C, Dow J, et al. A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracicechocardiography[J]. Cardiovascular Res, 1998, 39:216 - 223.
  • 5Meune C, Fulla Y, Martins E. et al, B-type natriuretic peptide for the diagnostic and prognostic assessment in cardiology its interest and perspectives of application [J]. Presse Med, 2003, 32: 181-185.
  • 6Martin R.C, Gustavo F.M. BNP and congestive heart failure [J]. Prog Cardiovasc Dis, 2002, 44: 293-321.

共引文献3

同被引文献8

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部